China's WuXi AppTec In Crosshairs of US Draft Biosecurity Bill

A draft US law is casting a cloud over some Chinese pharma firms, as it aims to block certain foreign biotech companies from accessing US federal contracts on national security grounds. Bloomberg's Michelle Cortez and Bernstein's Rebecca Liang discuss the implications.